NPPA Asks State, UT Govts to Ensure Availability of PPEs, Masks, Testing Kits And Ventilators

The National Pharmaceutical Pricing Authority (NPPA) on Wednesday asked the state and UT governments to ensure availability of essential medical equipment such as personal protective equipments (PPEs), masks, gloves, testing kits and ventilators.

In a letter to the chief secretaries of all state and UT governments, NPPA Chairperson Shubhra Singh said the government has notified all drugs as medical devices.

According to letter, “all medical devices (around 5,000 devices) have come under the jurisdiction of regulatory supervision for quality control and price monitoring. This is a major tool in fight with the emerging situation due to COVID-19,”

The letter asked them to provide by April 5 the production capacity of these medical devices in the state and number of procurement orders issued by the state government, government hospitals, other healthcare establishments, state public sector undertakings, co-operatives and private health services. It has also asked the chief secretaries to provide stock-in-hand at government hospitals, other healthcare establishments, state public sector undertakings, co-operatives and private health services.

Further, it asked them to provide details about stock-in-hand at retailers level and action to be taken by state government to meet out the emerging requirement in response to COVID-19.

The letter asked them to assess the requirements of state governments for PPEs, masks, gloves and ventilators for next two months, their current availability, shortfall and proposal to address shortage

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick